| Product Code: ETC9940790 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Chronic Hepatitis B (CHB) Market - Industry Life Cycle |
3.4 United Kingdom (UK) Chronic Hepatitis B (CHB) Market - Porter's Five Forces |
3.5 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Revenues & Volume Share, By Gender, 2021 & 2031F |
3.7 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about chronic hepatitis B among the population in the UK |
4.2.2 Advances in medical research leading to the development of more effective treatments |
4.2.3 Government initiatives and healthcare policies supporting the management of chronic hepatitis B |
4.3 Market Restraints |
4.3.1 High treatment costs and limited access to affordable healthcare services |
4.3.2 Stigma associated with chronic hepatitis B leading to underreporting and delayed diagnosis |
5 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Trends |
6 United Kingdom (UK) Chronic Hepatitis B (CHB) Market, By Types |
6.1 United Kingdom (UK) Chronic Hepatitis B (CHB) Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Revenues & Volume, By Antivirals, 2021- 2031F |
6.1.4 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Revenues & Volume, By Immune Modulators, 2021- 2031F |
6.2 United Kingdom (UK) Chronic Hepatitis B (CHB) Market, By Gender |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Revenues & Volume, By Male, 2021- 2031F |
6.2.3 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Revenues & Volume, By Female, 2021- 2031F |
6.3 United Kingdom (UK) Chronic Hepatitis B (CHB) Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Revenues & Volume, By Drug Stores and Retail Pharmacies, 2021- 2031F |
6.3.4 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Revenues & Volume, By Online Providers, 2021- 2031F |
7 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Export to Major Countries |
7.2 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Imports from Major Countries |
8 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Key Performance Indicators |
8.1 Number of patients undergoing regular screenings for chronic hepatitis B |
8.2 Percentage of chronic hepatitis B patients receiving appropriate treatment and care |
8.3 Rate of adherence to treatment regimens among chronic hepatitis B patients |
9 United Kingdom (UK) Chronic Hepatitis B (CHB) Market - Opportunity Assessment |
9.1 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Opportunity Assessment, By Gender, 2021 & 2031F |
9.3 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Chronic Hepatitis B (CHB) Market - Competitive Landscape |
10.1 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Chronic Hepatitis B (CHB) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here